Source: GlobalNewswire

Press Release: Casma : Casma Therapeutics Announces Addition of Sharon Tooze, Ph.D. to Scientific Advisory Board

CAMBRIDGE, Mass., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Casma Therapeutics, Inc., a biotechnology company harnessing the process of autophagy to design powerful new medicines, today announced the appointment of Sharon Tooze, Ph.D. to its scientific advisory board (SAB).

Read full article »

Casma's Competitors | Casma's News | Casma's Financials

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

25-100

President & CEO

Frank Gentile

CEO Approval Rating

83/100

Casma is a Massachusetts-based biotechnology company that develops therapies for the treatment of cancer, inflammation, neurodegeneration, and metabolic disorders.